ChinaBio Today -- At the recent ChinaBio® Partnering Forum held in Shanghai, the Keynote Panel discussed significant issues regarding doing partnering deals in China. The Panel was moderated by Gerald Chan, DSc, of Morningside Group, a long-standing member of the China venture capital and private equity worlds, whose investments have included over 30 biopharmas. The Panel included three China-based executives from big pharma and one executive from a highly innovative China pharmaceutical firm.
